BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 37590262)

  • 1. Epidemiologic and Clinical Features of Mpox in Adults Aged >50 Years - United States, May 2022-May 2023.
    Eustaquio PC; Salmon-Trejo LAT; McGuire LC; Ellington SR
    MMWR Morb Mortal Wkly Rep; 2023 Aug; 72(33):893-896. PubMed ID: 37590262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons - 43 U.S. Jurisdictions, July 31-October 1, 2022.
    Payne AB; Ray LC; Cole MM; Canning M; Houck K; Shah HJ; Farrar JL; Lewis NM; Fothergill A; White EB; Feldstein LR; Roper LE; Lee F; Kriss JL; Sims E; Spicknall IH; Nakazawa Y; Gundlapalli AV; Shimabukuro T; Cohen AL; Honein MA; Mermin J; Payne DC
    MMWR Morb Mortal Wkly Rep; 2022 Dec; 71(49):1560-1564. PubMed ID: 36480479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demographic and Clinical Characteristics of Mpox in Persons Who Had Previously Received 1 Dose of JYNNEOS Vaccine and in Unvaccinated Persons - 29 U.S. Jurisdictions, May 22-September 3, 2022.
    Farrar JL; Lewis NM; Houck K; Canning M; Fothergill A; Payne AB; Cohen AL; Vance J; Brassil B; Youngkin E; Glenn B; Mangla A; Kupferman N; Saunders K; Meza C; Nims D; Soliva S; Blouse B; Henderson T; Banerjee E; White B; Birn R; Stadelman AM; Abrego M; McLafferty M; Eberhart MG; Pietrowski M; De León SM; Creegan E; Diedhiou A; Wiedeman C; Murray-Thompson J; McCarty E; Marcinkevage J; Kocharian A; Torrone EA; Ray LC; Payne DC;
    MMWR Morb Mortal Wkly Rep; 2022 Dec; 71(5152):1610-1615. PubMed ID: 36580416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimated Effectiveness of JYNNEOS Vaccine in Preventing Mpox: A Multijurisdictional Case-Control Study - United States, August 19, 2022-March 31, 2023.
    Dalton AF; Diallo AO; Chard AN; Moulia DL; Deputy NP; Fothergill A; Kracalik I; Wegner CW; Markus TM; Pathela P; Still WL; Hawkins S; Mangla AT; Ravi N; Licherdell E; Britton A; Lynfield R; Sutton M; Hansen AP; Betancourt GS; Rowlands JV; Chai SJ; Fisher R; Danza P; Farley M; Zipprich J; Prahl G; Wendel KA; Niccolai L; Castilho JL; Payne DC; Cohn AC; Feldstein LR; ;
    MMWR Morb Mortal Wkly Rep; 2023 May; 72(20):553-558. PubMed ID: 37200229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JYNNEOS Vaccination Coverage Among Persons at Risk for Mpox - United States, May 22, 2022-January 31, 2023.
    Owens LE; Currie DW; Kramarow EA; Siddique S; Swanson M; Carter RJ; Kriss JL; Boersma PM; Lee FC; Spicknall I; Hurley E; Zlotorzynska M; Gundlapalli AV
    MMWR Morb Mortal Wkly Rep; 2023 Mar; 72(13):342-347. PubMed ID: 36995962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mpox vaccine and infection-driven human immune signatures: an immunological analysis of an observational study.
    Cohn H; Bloom N; Cai GY; Clark JJ; Tarke A; Bermúdez-González MC; Altman DR; Lugo LA; Lobo FP; Marquez S; ; Chen JQ; Ren W; Qin L; Yates JL; Hunt DT; Lee WT; Crotty S; Krammer F; Grifoni A; Sette A; Simon V; Coelho CH
    Lancet Infect Dis; 2023 Nov; 23(11):1302-1312. PubMed ID: 37475115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of JYNNEOS Vaccine Against Diagnosed Mpox Infection - New York, 2022.
    Rosenberg ES; Dorabawila V; Hart-Malloy R; Anderson BJ; Miranda W; O'Donnell T; Gonzalez CJ; Abrego M; DelBarba C; Tice CJ; McGarry C; Mitchell EC; Boulais M; Backenson B; Kharfen M; McDonald J; Bauer UE
    MMWR Morb Mortal Wkly Rep; 2023 May; 72(20):559-563. PubMed ID: 37339074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced Odds of Mpox-Associated Hospitalization Among Persons Who Received JYNNEOS Vaccine - California, May 2022-May 2023.
    Schildhauer S; Saadeh K; Vance J; Quint J; Salih T; Lo T; Keinde A; Chojolan E; Gotlieb E; Ramos M; Chapman E; Peters P; Watson J; Johnson KA; Tang EC; Jacobson K; Snyder RE
    MMWR Morb Mortal Wkly Rep; 2023 Sep; 72(36):992-996. PubMed ID: 37676838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine Effectiveness of JYNNEOS against Mpox Disease in the United States.
    Deputy NP; Deckert J; Chard AN; Sandberg N; Moulia DL; Barkley E; Dalton AF; Sweet C; Cohn AC; Little DR; Cohen AL; Sandmann D; Payne DC; Gerhart JL; Feldstein LR
    N Engl J Med; 2023 Jun; 388(26):2434-2443. PubMed ID: 37199451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress Toward Equitable Mpox Vaccination Coverage: A Shortfall Analysis - United States, May 2022-April 2023.
    Kota KK; Chesson H; Hong J; Zelaya C; Spicknall IH; Riser AP; Hurley E; Currie DW; Lash RR; Carnes N; Concepción-Acevedo J; Ellington S; Belay ED; Mermin J
    MMWR Morb Mortal Wkly Rep; 2023 Jun; 72(23):627-632. PubMed ID: 37289660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receipt of First and Second Doses of JYNNEOS Vaccine for Prevention of Monkeypox - United States, May 22-October 10, 2022.
    Kriss JL; Boersma PM; Martin E; Reed K; Adjemian J; Smith N; Carter RJ; Tan KR; Srinivasan A; McGarvey S; McGehee J; Henderson D; Aleshire N; Gundlapalli AV
    MMWR Morb Mortal Wkly Rep; 2022 Oct; 71(43):1374-1378. PubMed ID: 36301741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety Monitoring of JYNNEOS Vaccine During the 2022 Mpox Outbreak - United States, May 22-October 21, 2022.
    Duffy J; Marquez P; Moro P; Weintraub E; Yu Y; Boersma P; Donahue JG; Glanz JM; Goddard K; Hambidge SJ; Lewin B; Lewis N; Rouse D; Shimabukuro T
    MMWR Morb Mortal Wkly Rep; 2022 Dec; 71(49):1555-1559. PubMed ID: 36480476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for the Re-Emerging Human Monkeypox Virus.
    Lee W; Kim YJ; Lee SJ; Ahn DG; Kim SJ
    J Microbiol Biotechnol; 2023 Aug; 33(8):981-991. PubMed ID: 37519276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of Monkeypox Among Unvaccinated Persons Compared with Persons Receiving ≥1 JYNNEOS Vaccine Dose - 32 U.S. Jurisdictions, July 31-September 3, 2022.
    Payne AB; Ray LC; Kugeler KJ; Fothergill A; White EB; Canning M; Farrar JL; Feldstein LR; Gundlapalli AV; Houck K; Kriss JL; Lewis NM; Sims E; Smith DK; Spicknall IH; Nakazawa Y; Damon IK; Cohn AC; Payne DC
    MMWR Morb Mortal Wkly Rep; 2022 Oct; 71(40):1278-1282. PubMed ID: 36201401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monkeypox (Mpox) outbreak during COVID-19 pandemic-Past and the future.
    Aden D; Zaheer S; Kumar R; Ranga S
    J Med Virol; 2023 Apr; 95(4):e28701. PubMed ID: 36951352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress and prospects on vaccine development against monkeypox infection.
    Saadh MJ; Ghadimkhani T; Soltani N; Abbassioun A; Daniel Cosme Pecho R; Taha A; Jwad Kazem T; Yasamineh S; Gholizadeh O
    Microb Pathog; 2023 Jul; 180():106156. PubMed ID: 37201635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human monkeypox virus in the shadow of the COVID-19 pandemic.
    Khamees A; Awadi S; Al-Shami K; Alkhoun HA; Al-Eitan SF; Alsheikh AM; Saeed A; Al-Zoubi RM; Zoubi MSA
    J Infect Public Health; 2023 Aug; 16(8):1149-1157. PubMed ID: 37269693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monkeypox Virus Infections After 2 Preexposure Doses of JYNNEOS Vaccine - United States, May 2022-May 2024.
    Guagliardo SAJ; Kracalik I; Carter RJ; Braden C; Free R; Hamal M; Tuttle A; McCollum AM; Rao AK
    MMWR Morb Mortal Wkly Rep; 2024 May; 73(20):460-466. PubMed ID: 38781111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiologic and Clinical Features of Mpox-Associated Deaths - United States, May 10, 2022-March 7, 2023.
    Riser AP; Hanley A; Cima M; Lewis L; Saadeh K; Alarcón J; Finn L; Kim M; Adams J; Holt D; Feldpausch A; Pavlick J; English A; Smith M; Rehman T; Lubelchek R; Black S; Collins M; Mounsey L; Blythe D; Avalos MH; Lee EH; Samson O; Wong M; Stokich BD; Salehi E; Denny L; Waller K; Talley P; Schuman J; Fischer M; White S; Davis K; Caeser Cuyler A; Sabzwari R; Anderson RN; Byrd K; Gold JAW; Kindilien S; Lee JT; O'Connor S; O'Shea J; Salmon-Trejo LAT; Velazquez-Kronen R; Zelaya C; Bower W; Ellington S; Gundlapalli AV; McCollum AM; Zilversmit Pao L; Rao AK; Wong KK; Guagliardo SAJ
    MMWR Morb Mortal Wkly Rep; 2023 Apr; 72(15):404-410. PubMed ID: 37053126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mpox Knowledge, Attitudes, and Practices Among Persons Presenting for JYNNEOS Vaccination-District of Columbia, August to October 2022.
    Hassan R; Wondmeneh S; Gonzalez Jimenez N; Chapman K; Mangla A; Ashley P; Willut C; Lee M; Rhodes T; Gillani S; Copen C; Jackson DA; Waltenburg M; Delaney KP; Miles G; Agnew-Brune C; Oakley LP;
    Sex Transm Dis; 2024 Jan; 51(1):47-53. PubMed ID: 37921836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.